OPTIMISING STRATEGIES FOR MALARIA ELIMINATION: PRIMAQUINE, MASS DRUG ADMINISTRATION AND ARTEMISININ RESISTANCECATEGORY: SCIENTIFIC FREE PAPER

OPTIMISING STRATEGIES FOR MALARIA ELIMINATION: PRIMAQUINE, MASS DRUG ADMINISTRATION AND ARTEMISININ RESISTANCECATEGORY: SCIENTIFIC FREE PAPER

Bibliografske podrobnosti
Main Authors:	Maude, R, Socheat, D, Nguon, C, Yeung, S, White, L
Format:	Journal article
Izdano:	2011

Podobne knjige/članki

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
od: Maude, R, et al.
Izdano: (2012)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia.
od: Maude, R, et al.
Izdano: (2009)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
od: Day Nicholas PJ, et al.
Izdano: (2009-02-01)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia.
od: Yeung, S, et al.
Izdano: (2008)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
od: Maude, R, et al.
Izdano: (2014)

Artemisinin resistance: current status and scenarios for containment.
od: Dondorp, A, et al.
Izdano: (2010)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia
od: Socheat Doung, et al.
Izdano: (2008-05-01)

Mass primaquine treatment to eliminate vivax malaria: Lessons from the past
od: Kondrashin, A, et al.
Izdano: (2014)

The role of mathematical modelling in guiding the science and economics of malaria elimination
od: Maude, R, et al.
Izdano: (2010)

The role of mathematical modelling in guiding the science and economics of malaria elimination
od: Maude, R, et al.
Izdano: (2010)

The role of mathematical modelling in guiding the science and economics of malaria elimination.
od: Maude, R, et al.
Izdano: (2010)

Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
od: Richard O. Mwaiswelo, et al.
Izdano: (2022-02-01)

Artemisinin resistance: current status and scenarios for containment (vol 8, pg 272, 2010)
od: Dondorp, A, et al.
Izdano: (2010)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
od: Lubell, Y, et al.
Izdano: (2014)

Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil
od: JP Dean Goldring, et al.
Izdano: (1999-09-01)

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
od: Smithuis, F, et al.
Izdano: (2010)

Primaquine to prevent transmission of falciparum malaria.
od: White, N
Izdano: (2013)

Primaquine to prevent transmission of falciparum malaria
od: White, N
Izdano: (2013)

Primaquine to prevent transmission of falciparum malaria.
od: White, N
Izdano: (2013)

Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine
od: Seila Suon, et al.
Izdano: (2010-02-01)

Mass Drug Administration With Artemisinin-Piperaquine for the Elimination of Residual Foci of Malaria in São Tomé Island
od: Mingqiang Li, et al.
Izdano: (2021-07-01)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
od: André Daher, et al.
Izdano: (2019-09-01)

Artemisinin resistance in Plasmodium falciparum malaria.
od: Dondorp, A, et al.
Izdano: (2009)

Artemisinin resistance and malaria elimination: where are we now?
od: Hanboonkunupakarn, B, et al.
Izdano: (2022)

Artemisinin resistance and malaria elimination: Where are we now?
od: Borimas Hanboonkunupakarn, et al.
Izdano: (2022-09-01)

Feasibility of malaria elimination.
od: Maude, R, et al.
Izdano: (2011)

Feasibility of malaria elimination
od: Maude, R, et al.
Izdano: (2011)

Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
od: Nguyen Ngoc Pouplin, J, et al.
Izdano: (2024)

Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination
od: Julie Nguyen Ngoc Pouplin, et al.
Izdano: (2024-06-01)

Primaquine therapy for malaria.
od: Baird, J, et al.
Izdano: (2004)

Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial
od: McLean, ARD, et al.
Izdano: (2021)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience.
od: Yeung, S, et al.
Izdano: (2008)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
od: Leang, R, et al.
Izdano: (2016)

Primaquine for prevention of malaria in travelers.
od: Baird, J, et al.
Izdano: (2003)

Reinventing primaquine for endemic malaria.
od: Baird, J
Izdano: (2012)

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar
od: Thu, AM, et al.
Izdano: (2024)

The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?).
od: Maude, R, et al.
Izdano: (2009)

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar
od: Aung Myint Thu, et al.
Izdano: (2024-05-01)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience
od: Socheat Duong, et al.
Izdano: (2008-05-01)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
od: Leang, R, et al.
Izdano: (2016)